Vaccine Scheduler
Luxembourg: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 3 | 4 | 5 | 11 | 12 | 13 | 15-23 | 2 | 5-6 | 9 | 12-14 | 15-16 | 17 | 18 | ||||
| RSV | RSV1 | |||||||||||||||||
| Coronavirus disease (COVID-19) | COVID-192 | |||||||||||||||||
| rotavirus infection | ROTA | ROTA | ROTA | |||||||||||||||
| diphtheria | D | D3 | D | D | D | d4 | ||||||||||||
| tetanus | TT | TT3 | TT | TT | TT | TT4 | ||||||||||||
| pertussis | acP | acP3 | acP | acP | acP | acP4 | acp5 | |||||||||||
| poliomyelitis | IPV | IPV3 | IPV | IPV | IPV | IPV4 | ||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib3 | Hib | Hib | ||||||||||||||
| hepatitis B | HepB6 | HepB | HepB3 | HepB | HepB | HepB7 | ||||||||||||
| pneumococcal disease | PCV20 | PCV20 | PCV20 | PCV20 | PCV8 | PCV209 | ||||||||||||
| meningococcal disease | MenB | MenB | MenB | MCV4 | MCV410 | MCV411 | ||||||||||||
| measles | MEAS | MEAS | ||||||||||||||||
| mumps | MUMPS | MUMPS | ||||||||||||||||
| rubella | RUBE | RUBE | ||||||||||||||||
| varicella | VAR | VAR | ||||||||||||||||
| human papillomavirus infection | HPV9 (F/M) | |||||||||||||||||
| influenza | IIV312 | IIV313 | ||||||||||||||||
| herpes zoster | ZOS14 | |||||||||||||||||
Version:
Footnotes:
- The vaccine is offered to pregnant women between gestational weeks 32 and 36 as part of a dual strategy with monoclonal antibodies. vaccination can be proposed for Individuals 75+, especially residents in elderly care facilities, and 65+ with high-risk comorbidities (chronic respiratory or heart conditions, immunodeficiency, cancer, or blood malignancies)
- For pregnant individuals with comorbidities.
- For premature infants (born before 33 weeks) or with a birthweight <1500g, a 3+1 schedule is recommended
- Subsequent Tdacp-IPV booster every 10 years
- One booster dose every 10 years. Vaccination for pregnant women between 13-26 weeks gestation - Tdap or TdapIPV vaccine
- Babies born to a mother infected with hepatitis B will be offered a dose at birth simultaneously with HB immunoglobulin
- Catch-up if no history of vaccination
- For those not previously vaccinated with an increased risk of severe disease.
- for those at increased risk of complications or severe disease
- Booster dose of vaccine against invasive meningococcal disease ACWY
- Catch-up recommendation for those at increased risk of complications or severe disease also after the age of the general recommendation (https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite/202300606-vaccination-contre-le-menincocoques-mj-2023-vf.pdf)
- Seasonal influenza vaccination is recommended for specific risk groups including pregnant individuals and those at higher risk of severe disease (e.g., immunocompromised)
- Seasonal influenza vaccination is recommended for specific risk groups including pregnant individuals and those at higher risk of severe disease (e.g., immunocompromised).
- for immunosuppressed or ahead of period of immunosuppression. 2 doses 1-2 months apart.
More information available at:
https://sante.public.lu/fr/espace-citoyen/dossiers-thematiques/v/vaccination/calendrier-vaccinal.html https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/schema-vaccinal/schema-vaccinal-2024-dtperpoliohib.pdf
-------------------------------------------------------------------------------------------------------------------------
ADDITIONAL COMMENT
All infant vaccinations in Luxembourg are given free of charge. All subsequent adult vaccinations are not free of charge.
MAJOR HISTORICAL CHANGES
1986: The combined MMR vaccine was introduced in the national childhood vaccination schedule and recommended at 15-18 months of age
1994: The second MMR dose was introduced in the national childhood vaccination schedule and recommended at 5-7 years
2008: March 2008. HPV vaccination was introduced in the national childhood vaccination schedule for females aged 12 years with a catch-up programme up to 18 years of age
2018: MenC 2nd dose introduced at 15-16 years; MenB introduced for increased risk groups
2022: Update to the pneumococcal vaccination policy. use of PCV20. refer to https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
2023: MCV4 introduced in the programme. can be proposed to >16 years if at increased risk of infection
2024: revised scheme for primary infant vaccination moving to a 2+1 schedule
Date of last update: 17 February 2026.
-------------------------------------------------------------------------------------------------------------------------